Objective: To compare the levels of ischaemia modifi ed albumin between osteomyelitis patients and healthy controls. Method: The cross-sectional prospective study was conducted at Van Yüzüncü Yil University, Van, Turkey, from May 2018 to May 2019, and comprised inpatients diagnosed with osteomyelitis, and healthy controls. Serum IMA concentrations were determined spectrophotometrically at 470nm wavelength. Serum ischaemia modifi ed albumin levels were measured and compared between the patients and the controls. Data was analysed using SPSS 20. Results: Of the 77 subjects, 37(48%) were patients and 40(52%) were controls. Serum ischaemia modifi ed albumin level in patients was signifi cantly higher than controls (p<0.05). There was a signifi cant correlation between ischaemia modifi ed albumin and C-reactive protein levels (p<0.05). Conclusion: Serum ischaemia modifi ed albumin level in patients was signifi cantly higher than controls (p<0.05).